Skip to main content

Reexamining Risk Aversion: Willingness to Pursue and Utilize Nonideal Donor Livers Among US Donation Service Areas.

Publication ,  Journal Article
Halpern, SE; Samoylova, ML; Shaw, BI; Kesseli, SJ; Hartwig, MG; Patel, YA; McElroy, LM; Barbas, AS
Published in: Transplant Direct
September 2021

BACKGROUND: Livers from "nonideal" but acceptable donors are underutilized; however, organ procurement organization (OPO) metrics do not assess how OPO-specific practices contribute to these trends. In this analysis, we evaluated nonideal liver donor avoidance or risk aversion among OPOs and within US donation service areas (DSAs). METHODS: Adult donors in the United Network for Organ Sharing registry who donated ≥1 organ for transplantation between 2007 and 2019 were included. Nonideal donors were defined by any of the following: age > 70, hepatitis C seropositive, body mass index > 40, donation after circulatory death, or history of malignancy. OPO-specific performance was evaluated based on rates of nonideal donor pursuit and consent attainment. DSA performance (OPO + transplant centers) was evaluated based on rates of nonideal donor pursuit, consent attainment, liver recovery, and transplantation. Lower rates were considered to represent increased donor avoidance or increased risk aversion. RESULTS: Of 97 911 donors, 31 799 (32.5%) were nonideal. Unadjusted OPO-level rates of nonideal donor pursuit ranged from 88% to 100%. In a 5-tier system of overall risk aversion, tier 5 DSAs (least risk-averse) and tier 1 DSAs (most risk-averse) had the highest and lowest respective rates of non-ideal donor pursuit, consent attainment, liver recovery, and transplantation. On average, recovery rates were over 25% higher among tier 5 versus tier 1 DSAs. If tier 1 DSAs had achieved the same average liver recovery rate as tier 5 DSAs, approximately 2100 additional livers could have been recovered during the study period. CONCLUSION: Most OPOs aggressively pursue nonideal liver donors; however, recovery practices vary widely among DSAs. Fair OPO evaluations should consider early donation process stages to best disentangle OPO and center-level practices.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Transplant Direct

DOI

ISSN

2373-8731

Publication Date

September 2021

Volume

7

Issue

9

Start / End Page

e742

Location

United States

Related Subject Headings

  • 3204 Immunology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Halpern, S. E., Samoylova, M. L., Shaw, B. I., Kesseli, S. J., Hartwig, M. G., Patel, Y. A., … Barbas, A. S. (2021). Reexamining Risk Aversion: Willingness to Pursue and Utilize Nonideal Donor Livers Among US Donation Service Areas. Transplant Direct, 7(9), e742. https://doi.org/10.1097/TXD.0000000000001173
Halpern, Samantha E., Mariya L. Samoylova, Brian I. Shaw, Samuel J. Kesseli, Matthew G. Hartwig, Yuval A. Patel, Lisa M. McElroy, and Andrew S. Barbas. “Reexamining Risk Aversion: Willingness to Pursue and Utilize Nonideal Donor Livers Among US Donation Service Areas.Transplant Direct 7, no. 9 (September 2021): e742. https://doi.org/10.1097/TXD.0000000000001173.
Halpern SE, Samoylova ML, Shaw BI, Kesseli SJ, Hartwig MG, Patel YA, et al. Reexamining Risk Aversion: Willingness to Pursue and Utilize Nonideal Donor Livers Among US Donation Service Areas. Transplant Direct. 2021 Sep;7(9):e742.
Halpern, Samantha E., et al. “Reexamining Risk Aversion: Willingness to Pursue and Utilize Nonideal Donor Livers Among US Donation Service Areas.Transplant Direct, vol. 7, no. 9, Sept. 2021, p. e742. Pubmed, doi:10.1097/TXD.0000000000001173.
Halpern SE, Samoylova ML, Shaw BI, Kesseli SJ, Hartwig MG, Patel YA, McElroy LM, Barbas AS. Reexamining Risk Aversion: Willingness to Pursue and Utilize Nonideal Donor Livers Among US Donation Service Areas. Transplant Direct. 2021 Sep;7(9):e742.

Published In

Transplant Direct

DOI

ISSN

2373-8731

Publication Date

September 2021

Volume

7

Issue

9

Start / End Page

e742

Location

United States

Related Subject Headings

  • 3204 Immunology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology